Lomustine 40mg
Product Overview
| Generic Name | Lomustine 40mg |
| Brand Name(s) | Gleostine, CCNU, CeeNu, Ceenu, Lomuwin, Lomoother, Belustine |
| Category | Antineoplastic / Cancer |
| Form | Oral hard gelatin capsules /100 Cap Package |
| Strength | 40 mg |
| Therapeutic Class | Alkylating agent (nitrosourea) |
| ATC Code | L01AD02 |
Manufacturing & Regulatory
| Manufacturer | GSK, Chandra Bhagat, Samarth Life Sciences, TherDose, Intas, Saintroy, Ocean Pharma, Lexicare, PBP, Blue Earth, |
| GMP Compliance | ISO, cGMP, USFDA/EUGMP, WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | Registered in Mexico |
| Free Sale Certificate | Available per batch upon request |
Logistics & Export
| MOQ | 20 packs/boxes of 100 Caps |
| Shelf Life | 24 Months |
| Storage | Room temperature (15–30 °C) or cool and dry place |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 to 10 Days |
Documentation Available Upon Request
| Certificate of Analysis (PDF) | Available from manufacturer/distributor |
| SDS-Safety Data Sheet (PDF) | Handling guidelines for cytotoxic alkylating agents available from suppliers |
| CTD Summary (PDF) | Not publicly available; may be provided by originator under NDA or with commercial engagement |
Special Notes
Indications & Usage: Lomustine is used orally to treat recurrent high-grade gliomas, Hodgkin’s lymphoma, melanoma, lung cancer, and other malignancies.